RoddyMedical Secures Strategic Funding to Expand Wearable Patient Safety Technology
RoddyMedical, a Wisconsin-based medical device company dedicated to improving patient safety and clinical workflows, has expanded its funding profile with a mix of early-stage seed financing and more recent strategic investment from a sector-focused venture group. Founded in 2018 by registered nurse and CEO Lindsey Roddy to address hazards associated with medical tubing and line dislodgements in clinical settings, the company develops and commercializes its patented wearable device, SecureMove‑TLC®, which secures and organizes medical tubes, IV lines, and cords to enhance patient safety and staff efficiency during therapy, transport, and movement.
RoddyMedical’s earliest known funding activity traces back to August 2021, when the company closed a $600,000 seed financing to support manufacturing scale-up and product launch for SecureMove‑TLC®. This seed round was backed by Wisconsin-based early-stage investors including Winnow Fund and Winnebago Seed Fund, both part of the Badger Fund of Funds initiative focused on strengthening the state’s startup ecosystem. The capital from these investors helped drive early commercial development, prototype production, and preparation for initial product distribution.
Subsequent funding activity and support for RoddyMedical include smaller investments from other regional backers in the Midwest medtech and healthcare innovation community. BrightStar Wisconsin Foundation also contributed to the company’s early growth with an investment that supported production and inventory scaling for SecureMove‑TLC®. These early infusions of capital, combined with grants and program support from organizations like the University of Wisconsin‑Milwaukee’s Innovate initiatives and I‑Corps programs, laid the groundwork for the company’s product commercialization and clinical traction.
In December 2025, RoddyMedical announced a more recent investment from Nurse Capital, a Chicago-based venture capital firm that specializes in backing nurse-led startups. The terms of this financing were not publicly disclosed, but the investment from Nurse Capital reflects growing interest in clinically grounded innovations developed by healthcare professionals themselves. Nurse Capital’s participation underscores recognition of the SecureMove‑TLC® device’s potential to reduce patient harm, improve clinical workflow efficiency, and deliver measurable operational value to hospitals and care facilities.
RoddyMedical’s funding story reflects a blend of regional seed support and later strategic investment from healthcare-focused venture entities. The company’s flagship SecureMove‑TLC® device — a wearable, single-use solution that can be worn for up to 30 days — is already being used in hospitals across multiple U.S. states, including facilities such as Mayo Clinic (Phoenix, AZ), Barnes‑Jewish Hospital (St. Louis, MO), and The Ohio State University Hospital. The product has also secured multiple global patents, adding to its competitive positioning as a patient safety and mobility solution for critical care environments.
The SecureMove‑TLC® technology was developed directly out of Roddy’s clinical experience, after a near-miss event in the ICU highlighted the dangers of unsecured tubing and lines during patient therapy movement. That event catalyzed the design and testing effort that ultimately resulted in a Class I medical device capable of mitigating significant pull forces and helping prevent hazardous line dislodgements that can lead to clinical complications, costly interventions, and extended care time.
The company’s growth and funding activity also coincide with broader efforts to support clinician-led innovation in healthcare technology. RoddyMedical was selected to participate in prominent industry programs such as the Mayo Clinic & ASU MedTech Accelerator, where its SecureMove‑TLC® device earned distinguished recognition and helped expand the company’s network of clinical and industry advisors. Participation in accelerator programs and investor engagements has enhanced RoddyMedical’s visibility among both clinical and investment communities.
Overall, RoddyMedical’s funding history — from early seed investments by regional venture partners to more recent backing from Nurse Capital — showcases growing investor confidence in its mission to improve patient safety through wearable medical technology. The company is also actively raising a Series A funding round of approximately $5 million to expand manufacturing capacity and increase market penetration of the SecureMove‑TLC® product across the broader U.S. healthcare system.
With its combination of clinician insight, patented technology, and strategic investor support, RoddyMedical is positioning itself to scale both production and adoption of its patient safety solutions, potentially setting new standards in clinical line management and mobility support across acute care environments.
